verapamil has been researched along with Respiratory Tract Diseases in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khan, H | 1 |
Saeed, M | 1 |
Mehmood, MH | 1 |
Rehman, NU | 1 |
Muhammad, N | 1 |
Haq, IU | 1 |
Ashraf, N | 1 |
El-Tahir, KE | 1 |
Gilani, AH | 3 |
Khan, M | 1 |
Khan, AU | 2 |
Bashir, S | 1 |
3 other studies available for verapamil and Respiratory Tract Diseases
Article | Year |
---|---|
Studies on tracheorelaxant and anti-inflammatory activities of rhizomes of Polygonatum verticillatum.
Topics: Animals; Anti-Inflammatory Agents; Calcium Channel Blockers; Carbachol; Carrageenan; Edema; Female; | 2013 |
Pharmacological explanation for the medicinal use of Juniperus excelsa in hyperactive gastrointestinal and respiratory disorders.
Topics: Animals; Bronchodilator Agents; Calcium Channel Blockers; Diarrhea; Gastrointestinal Diseases; Guine | 2012 |
Pharmacological basis for the use of Borago officinalis in gastrointestinal, respiratory and cardiovascular disorders.
Topics: Animals; Aorta; Borago; Calcium; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; | 2007 |